Partnering with a China CDMO for Inhalation Devices: FAQ

Answers on what a China CDMO can offer for inhalation devices (SMI, DPI, pMDI & mesh nebulizer), the due-diligence checklist, and risks to manage before partnering.

What can a China CDMO offer for inhalation devices?

A China CDMO offers multiple device platforms (SMI, DPI, pMDI, and mesh nebulizer) under one partner, OEM/ODM and CDMO services including design, tooling, assembly, private labeling and customization, quality systems certified under FDA, CE MDR, and ISO 13485, and scale and cost efficiency from established manufacturing infrastructure and supply chains.

How should I do due diligence before partnering with a China CDMO?

Verify the FDA registration and any relevant device listings, confirm the ISO 13485 quality management scope covers the device type, review the CE marking scope and technical file readiness, audit the facility and request batch records, material certificates, and validation, and clarify IP, change control, and quality agreements in writing.

What risks should I manage when working with a China CDMO?

Confirm regulatory documents are current and scoped to your product, validate reproducibility across batch scales, and establish clear communication and project governance.

Can a China CDMO deliver compliant, cost-effective inhalation devices?

China's inhalation-device manufacturing has matured significantly. With disciplined due diligence, a China CDMO can be a strong, compliant partner for bringing an inhalation product to market cost-effectively. This overview is for general reference; always verify a manufacturer's current regulatory status with the relevant authorities for your market and product.

Which inhalation platforms should a CDMO partner be able to provide?

A capable CDMO partner should provide multiple platforms, typically SMI, DPI, pMDI, and mesh nebulizer, allowing you to match the formulation to the right delivery platform under one partner.

Why consider a China-based CDMO for respiratory drug development?

Global respiratory drug developers partner with China-based CDMOs to accelerate development and reduce cost without sacrificing quality, provided due diligence is done properly.

Manufacturer note: Changzhou DSB Medical Co., Ltd. (China) offers inhalation device manufacturing with SMI, DPI, pMDI, and mesh nebulizer platforms under FDA, CE MDR, and ISO 13485 certified quality systems, with OEM/ODM CDMO services. Learn more: China medical device manufacturer — DSB Medical.